Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Patients with Angioid Streaks
1
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
Purpose: To evaluate the functional and anatomic outcomes of photodynamic therapy (PDT) for choroidal neovascularization (CNV) in patients with angioid streaks. Methods: The authors retrospectively evaluated 6 consecutive patients (6 eyes) with CNV secondary to angioid streaks. All patients were treated with standard PDT with verteporfin protocol. Standardized protocol refraction, visual acuity testing, ophthalmologic examination, color photographs, fluorescein angiograms and indocyanin angiograms were used to evaluate the results of PDT with verteporfin. Main outcome measures were visual acuity and CNV size. Results: Their mean age was 61.3±5.50 years (range, 53-68 years). Follow-up time ranged from 12 to 38 months with mean of 20.5±10.91 months. The mean visual acuity at baseline was 20/100 (range 20/25-20/500), and the mean visual acuity at the last examination was 20/320(range 20/125-counting finger). The mean greatest linear dimension (GLD) at baseline was 2400±766.81 µm, and the mean GLD at the last examination was 3483±444.59 µm. Conclusions: PDT for CNV associated with angioid streaks seemed to slow down but not prevent the progression of the disease and associated visual loss.
참고문헌 (17)
- &enote, "et al. Macular degeneration in angioid streaks. Ophthalmologica 1988", pp.36~41
- Singerman LJ, "Hatem G. Laser treatment of choroidal neovascular membranes in angioid streaks. Retina 1981", pp.75~83
- Lim JI, "Bressler SB. Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 1993", pp.414~23
- Pece A, "Laser photocoagulation of choroidal neovascularization in angioid streaks", 17, pp.12~16 (1997)
- Gelisken O, "Deutman AF. A long-term follow-up study of laser coagulation of neovascular membranes in angioid streaks. Am J Ophthalmol 1988", pp.299~303
- Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group, "Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:one-year results of 2 randomized clinical trials-TAP report", 117, pp.1329~1345 (1999)
- Verteporfin in Photodynamic Therapy Study Group, "Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin:1-year results of a randomized clinical trial-VIP report no. 1", 108, pp.841~852 (2001)
- Sickenberg M, "A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes", 118, pp.327~336 (2000)
- Karacorlu M, "Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks", 134, pp.360~366 (2002)
- Menchini U, "Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy", 24, pp.763~771 (2004)
- Shaikh S, "Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks", 135, pp.1~6 (2003)
- Browning AC, "Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks", 112, pp.1227~1231 (2005)
- Heimann H, "Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks", 243, pp.1115~1123 (2005)
- Arias L, "Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks", 244, pp.753~757 (2006)
- Jurklies B, "Photodynamic therapy using verteporfin for choroidal neovascularization associated with angioid streaks-long-term effects", 38, pp.209~217 (2006)
- Spaide RF, "Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization", 110, pp.1517~1525 (2003)
- Eyetech Study Group, "Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase Ⅱ study results", 110, pp.979~986 (2003)
